top of page

Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study

About the study

NCT Trial Number

NCT04505189

The drug being studied

Psilocybin

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

Imperial College London

noun_date_3237048.png

Trial Start Date

Oct-20

noun_capsule_138144.png

About the participants

Age seeking

21 Years to 65 Years

gender

Female

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Eating Disorder

noun_square_138133.png

Accepts healthy volunteers?

No

To assess the acceptability and efficacy of treating anorexia with psilocybin.
Secondly, the study will use brain imaging techniques to explore the brain changes related to treatment with psilocybin in this patient group.

Eyes Graffiti

Locations

United Kingdom
Imperial College London, London, United Kingdom
Meg J Spriggs, PhD
m.spriggs@imperial.ac.uk

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page